Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Polycythemia Vera 11 Brain Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Leukemia 9 Glioblastoma 9 Leukemia, Myeloid, Acute 8 Meningioma 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Laryngeal Neoplasms 3 Esophageal Neoplasms 3 Treatment-Refractory Solid Tumors 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Primary Myelofibrosis 2 Pharyngeal Neoplasms 2 Paranasal Sinus Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Hypopharyngeal Neoplasms 2

Interventions

Tretinoin 27 Arsenic Trioxide 27 Cytarabine 20 Cyclophosphamide 14 Methotrexate 13 Idarubicin 13 Busulfan 11 Filgrastim 10 Etoposide 8 fludarabine phosphate 7 Peripheral Blood Stem Cell Transplantation 7 Mercaptopurine 7 Gemtuzumab 7 Daunorubicin 7 Radiotherapy 6 Tacrolimus 5 Mitoxantrone 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Sorafenib 4 Antilymphocyte Serum 4 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 Azacitidine 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Hydroxyurea × Clear all

NCT02899169 2021-09-08

APL16

First Affiliated Hospital Xi'an Jiaotong University

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡